'People, Infrastructure and Processes that Differ Remarkably from Competitors'

Dr. Rolf Kuropka, managing director, Krahn Chemie
Dr. Rolf Kuropka, managing director, Krahn Chemie

What kind of growth do you aspire to in the next few years; in which sectors, markets or regions do you see significant growth opportunities?

Krahn Chemie will consequently follow its growth strategy: regional expansion to countries attractive for distributors and strengthening of the product portfolio of the segments Krahn Chemie is active in, i.e., coatings and construction chemicals, plastics, rubber, technical ceramics, adhesives, and lubricants. We still believe that even in a quite mature market like the EU, a company can gain additional market share by offering people, infrastructure and processes that differ remarkably from competitors.

How do you intend to implement these plans and seize these opportunities?

With the acquisition of the ICH Benelux Group in 2013 and more recently Pietro Carini in Italy, Krahn Chemie took two major steps to expand its market position in Europe and to strengthen its portfolio and competencies. We will continue to follow this path, and we also go on winning attractive distributions rights of the tier 1 suppliers of the world. Our central laboratory in Bottrop as well as local laboratories in the main region will support our technically driven approach. The target is to become the preferred specialty chemical distributor in Europe.

 

Company

Krahn Chemie

Mühlenhagen 35
20539 Hamburg
Germany

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.